|
1
|
Macià M, Rubio C, Romero J, Hervas A, Vera A, Britton R, Zunino S, Solé J, de la Torre M, Fernández A, Trigo L, Rodrigues R, Salgado ML. In response to ESTRO 2012 strategy meeting: vision for Radiation Oncology (published April 2012). Radiother Oncol 2013; 109:181-2. [PMID: 24060172 DOI: 10.1016/j.radonc.2013.08.042] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2012] [Accepted: 08/30/2013] [Indexed: 11/30/2022]
Affiliation(s)
- Miquel Macià
- Department of Radiation Oncology, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
|
2
|
|
|
3
|
Linares L, Poitevin A, De la Pena C, Britton KR, Ospino R, Lara R, Sarria G, Motta N, Rene N, Pinillos L, Novaes P. The prescription of oral anticancer drugs: Another perspective. Rep Pract Oncol Radiother 2012; 17:295-7. [PMID: 24377031 DOI: 10.1016/j.rpor.2012.10.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- Luis Linares
- HOPE International Radiation Center, Guatemala, Guatemala
| | - Adela Poitevin
- Department of Radiation Oncology, Médica Sur, Mexico City, Mexico
| | | | - Keith R Britton
- Centro Internacional de Radiocirugía y Radioterapia Oncológica (CIRRO), Panamá, Panama
| | | | - Raul Lara
- Centro Salvadoreño de Radioterapia, San Salvador, El Salvador
| | - Gustavo Sarria
- Department of Radiation Oncology, National Institute for Neoplastic Diseases (INEN), Lima, Peru
| | - Neiro Motta
- Radioterapia, ISCMPA/UFCSPA, Porto Alegre, Brazil
| | | | | | - Paulo Novaes
- Radioterapia - ISO Hospital Dia Santos, São Paulo, Brazil
| | | |
Collapse
|
|
4
|
Ramos A, Torrecilla JL, Lara P, Herruzo I, Contreras J, Mañas A, Guedea F. Should the prescription of oral anticancer drugs be restricted? Rep Pract Oncol Radiother 2012; 17:187-9. [PMID: 24377022 DOI: 10.1016/j.rpor.2012.07.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
| | | | - Pedro Lara
- Hospital Universitario de Gran Canaria Dr. Negrín, Canary Islands, Spain
| | - Ismael Herruzo
- Hospital Regional Universitario Carlos Haya, Málaga, Spain
| | | | | | | | | |
Collapse
|
|
5
|
Galofré JC, Gómez-Sáez JM, Escola CA, Anda E, Calleja A, Donnay S, Lucas-Martin A, Menéndez-Torre E, Pereg V, Pérez-Corral B, Santamaría J, Riesco-Eizaguirre G, Zafon C. Treatment of thyroid cancer with the new oral agents. Ann Oncol 2011; 22:2343. [PMID: 21859897 DOI: 10.1093/annonc/mdr409] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|